electroCore to Participate in Upcoming Virtual Investor Conferences

Rhea-AI Summary

electroCore (Nasdaq: ECOR) has announced that CEO Dan Goldberger and CFO Brian Posner will participate in two upcoming investor conferences on November 19, 2020. The first event is the Sidoti Virtual Microcap Conference 2020, featuring a corporate presentation and 1x1 meetings from 10:45am to 11:45am ET. The second event is the Canaccord Genuity Virtual MedTech & Diagnostics Forum, also consisting of 1x1 meetings. The company specializes in non-invasive vagus nerve stimulation therapy, targeting conditions in neurology such as migraine and cluster headaches.

BASKING RIDGE, N.J., Nov. 12, 2020 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, announced today that Dan Goldberger, Chief Executive Officer, and Brian Posner, Chief Financial Officer, will participate in two upcoming investor conferences:

Sidoti Virtual Microcap Conference 2020
Format: corporate presentation followed by 1x1 virtual investor meetings
Date: Thursday, November 19
Time: 10:45am – 11:45am ET

Investors can register for the webcast HERE.

Canaccord Genuity Virtual MedTech & Diagnostics Forum
Format: 1x1 virtual investor meetings
Date: Thursday, November 19

About electroCore, Inc.

electroCore, Inc. is a commercial stage bioelectronic medicine company dedicated to improving patient outcomes through its platform non-invasive vagus nerve stimulation therapy initially focused on the treatment of multiple conditions in neurology. The company’s current indications are the preventative treatment of cluster headache and migraine and acute treatment of migraine and episodic cluster headache.

For more information, visit www.electrocore.com.

Investors:

Hans Vitzthum
LifeSci Advisors
617-430-7578
hans@lifesciadvisors.com

or

Media Contact:

Jackie Dorsky
electroCore
973-290-0097
jackie.dorsky@electrocore.com

FAQ

What is the date of the upcoming investor conferences for electroCore (ECOR)?

The investor conferences for electroCore (ECOR) are scheduled for November 19, 2020.

Who will represent electroCore at the investor conferences?

CEO Dan Goldberger and CFO Brian Posner will represent electroCore at the investor conferences.

What is the format of the Sidoti Virtual Microcap Conference?

The Sidoti Virtual Microcap Conference will include a corporate presentation followed by 1x1 virtual investor meetings.

What conditions does electroCore's therapy target?

electroCore's therapy primarily targets the preventative treatment of cluster headaches and migraines, as well as acute treatments for these conditions.

How can investors register for the electroCore conference webcast?

Investors can register for the webcast by visiting the link provided in the press release.